Investment supports emerging entrepreneurial scientists and critical proof-of-principle studies
TORONTO, Feb. 20, 2018 /PRNewswire/ – FACIT, a business accelerator, announced four new recipients of funding through its Prospects oncology investment competition: Dalriada Therapeutics…
